-
Signature
-
Michael Harrity, by Power of Attorney
-
Issuer symbol
-
HCSG
-
Transactions as of
-
24 Feb 2026
-
Net transactions value
-
-$154,658
-
Form type
-
4
-
Filing time
-
26 Feb 2026, 16:06:20 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| SHEA JOHN CHRISTOPHER |
EVP & Chief Admin. Officer |
3220 TILLMAN DRIVE, SUITE 300, BENSALEM |
Michael Harrity, by Power of Attorney |
26 Feb 2026 |
0001502211 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
HCSG |
Common Stock |
Options Exercise |
$0 |
+4,416 |
+15% |
$0.000000 |
33,708 |
24 Feb 2026 |
Direct |
|
| transaction |
HCSG |
Common Stock |
Tax liability |
$40,104 |
-1,874 |
-5.6% |
$21.40 |
31,834 |
24 Feb 2026 |
Direct |
F1 |
| transaction |
HCSG |
Common Stock |
Options Exercise |
$0 |
+12,618 |
+40% |
$0.000000 |
44,452 |
24 Feb 2026 |
Direct |
F2 |
| transaction |
HCSG |
Common Stock |
Tax liability |
$114,554 |
-5,353 |
-12% |
$21.40 |
39,099 |
24 Feb 2026 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
HCSG |
Restricted Stock Units |
Options Exercise |
$0 |
-4,416 |
-33% |
$0.000000 |
8,830 |
24 Feb 2026 |
Common Stock |
4,416 |
|
Direct |
F3, F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: